Two Sigma Securities, LLC Biomarin Pharmaceutical Inc Put Options Transaction History

Two Sigma Securities, LLC

$5.78 Billion
Q3 2024

Put Options

19 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$69.02 - $93.84 $669,494 - $910,248	-9,700 Reduced 75.19%	3,200 $224,000
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $573,111 - $710,094	7,700 Added 148.08%	12,900 $1.06 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $217,906 - $257,400	2,600 Added 100.0%	5,200 $454,000
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $198,172 - $256,126	2,600 New	2,600 $250,000
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $201,879 - $230,769	-2,700 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $203,877 - $228,933	2,700 New	2,700 $225,000
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $291,447 - $353,691	-3,900 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $29,044 - $36,080	-400 Reduced 9.3%	3,900 $342,000
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $86,244 - $157,236	-1,200 Reduced 21.82%	4,300 $327,000
Q2 2020 Sep 10, 2020	BUY	$79.55 - $124.22 $246,605 - $385,082	3,100 Added 129.17%	5,500 $678,000
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $1.4 Million - $1.9 Million	-19,600 Reduced 89.09%	2,400 $203,000
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $1.12 Million - $1.5 Million	17,400 Added 378.26%	22,000 $1.86 Million
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $384,180 - $485,127	-5,700 Reduced 55.34%	4,600 $310,000
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $305,330 - $356,820	3,800 Added 58.46%	10,300 $882,000
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $261,020 - $305,722	3,100 Added 91.18%	6,500 $577,000
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $857,498 - $1.13 Million	-10,700 Reduced 75.89%	3,400 $290,000
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $2.76 Million - $3.11 Million	-29,400 Reduced 67.59%	14,100 $1.37 Million
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $980,529 - $1.28 Million	12,900 Added 42.16%	43,500 $4.1 Million
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $2.38 Million - $2.83 Million	30,600 New	30,600 $2.48 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.53 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.3 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.27 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$936 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$707 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account